|
Index of reports
> Cases with Neuroleptic Malignant Syndrome ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Abilify (Aripiprazole) where reactions include neuroleptic malignant syndrome. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of Next >>
Possible Abilify side effects in 31 year old male
Reported by a physician from Japan on 2012-08-27
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Pneumonia Staphylococcal
Adverse event resulted in: death
Drug(s) suspected as cause:
Methotrimeprazine Maleate
Levotomin
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Rohypnol
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Other drugs received by patient: Diazepam; Promethazine HCL; Miya-BM
Possible Abilify side effects in 31 year old male
Reported by a pharmacist from Japan on 2012-08-27
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Pneumonia Staphylococcal
Adverse event resulted in: death
Drug(s) suspected as cause:
Methotrimeprazine Maleate
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Rohypnol
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Levotomin
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Other drugs received by patient: Diazepam; Promethazine HCL; Miya-BM
Possible Abilify side effects in 49 year old male
Reported by a consumer/non-health professional from France on 2012-08-23
Patient: 49 year old male
Reactions: Cytolytic Hepatitis, Neuroleptic Malignant Syndrome, Drug Withdrawal Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alprazolam
Administration route: Oral
End date: 2012-07-01
Mirtazapine
Dosage: formulation: tabs
Administration route: Oral
Abilify
Dosage: until jul12
Administration route: Oral
Indication: Schizophrenia
Mianserin HCL
End date: 2012-07-01
Possible Abilify side effects in 31 year old male
Reported by a consumer/non-health professional from Japan on 2012-08-16
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Pneumonia Staphylococcal, Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Levotomin
Administration route: Oral
Start date: 2012-06-01
Methotrimeprazine Maleate
Rohypnol
Start date: 2012-06-01
Other drugs received by patient: Promethazine HCL; Miya-BM; Diazepam
Possible Abilify side effects in 60 year old male
Reported by a consumer/non-health professional from Japan on 2012-08-13
Patient: 60 year old male, weighing 53.0 kg (116.6 pounds)
Reactions: Pneumonia, Drug Ineffective, Hypoglycaemia, Hepatic Failure, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Abilify
Dosage: 27jun07-2jul07;12mg,6days.03-jul-11jul 24mg/day.15mg 12jul-7aug:30mg, 3week 6days. also 6mg
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-06-27
End date: 2007-08-07
Levotomin
Dosage: 50 mg 4 weeks 1day. 31jul07-7aug07;dose increased to 150 mg on 31jul07, 1week 1day. tabs 100mg 1jn07
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-07-02
End date: 2007-08-07
Other drugs received by patient: Ringers Solution, Lactated; Biperiden Lactate; Doral; Haloperidol; Amoxicillin; Biperiden Hydrochloride TAB; Flunitrazepam; Maintenance Medium 5; Silece; Cefotiam Hydrochloride
Possible Abilify side effects in 31 year old male
Reported by a pharmacist from Japan on 2012-08-03
Patient: 31 year old male
Reactions: Eosinophilic Pneumonia, Haemorrhage, Interstitial Lung Disease, Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-07-02
Risperdal
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-29
End date: 2012-07-02
Risperdal
Administration route: Oral
Start date: 2012-06-04
End date: 2012-06-29
Haloperidol
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-07-02
Possible Abilify side effects in 31 year old male
Reported by a consumer/non-health professional from Japan on 2012-08-02
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Pneumonia Staphylococcal, Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Levotomin
Administration route: Oral
Start date: 2012-06-01
Other drugs received by patient: Miya-BM; Promethazine HCL; Rohypnol; Diazepam
Possible Abilify side effects in 47 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-16
Patient: 47 year old male, weighing 79.0 kg (173.8 pounds)
Reactions: Neuroleptic Malignant Syndrome, Withdrawal Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aripiprazole
Dosage: inj
Indication: Schizophrenia
Start date: 2011-12-12
End date: 2012-04-02
Abilify
Dosage: 07aug07-26sep11;12mg,27sep11-02oct11;24mg,03oct11-12apr12;193d
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-08-07
End date: 2012-04-12
Placebo
Other drugs received by patient: Diovan; Famotidine; Cleanal; Mucosta; Olopatadine HCL; Onon; Livostin; Calslot; Risperdal
Possible Abilify side effects in 49 year old female
Reported by a consumer/non-health professional from Japan on 2012-07-04
Patient: 49 year old female, weighing 45.0 kg (99.0 pounds)
Reactions: Neuroleptic Malignant Syndrome, Posture Abnormal, Salivary Hypersecretion
Drug(s) suspected as cause:
Abilify
Other drugs received by patient: Biperiden Hydrochloride TAB; Clonazepam; Promazine Hydrochloride; Flunitrazepam; Trialam; Sennoside
Possible Abilify side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-25
Patient: 49 year old female, weighing 45.0 kg (99.0 pounds)
Reactions: Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Pain, Blood Lactate Dehydrogenase Increased, Posture Abnormal, Pyrexia, Aspartate Aminotransferase Increased, Psychiatric Symptom, Salivary Hypersecretion, Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Abilify
Other drugs received by patient: Flunitrazepam; Trialam; Clonazepam; Biperiden Hydrochloride TAB; Promazine Hydrochloride; Sennoside
Possible Abilify side effects in 49 year old female
Reported by a consumer/non-health professional from Japan on 2012-06-10
Patient: 49 year old female
Reactions: Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Pain, Posture Abnormal, Pyrexia, Aspartate Aminotransferase Increased, Psychiatric Symptom, Neuroleptic Malignant Syndrome, Salivary Hypersecretion
Drug(s) suspected as cause:
Abilify
Other drugs received by patient: Trialam; Flunitrazepam; Clonazepam; Promazine Hydrochloride; Sennoside; Biperiden Hydrochloride TAB
Possible Abilify side effects in 45 year old male
Reported by a consumer/non-health professional from Japan on 2012-06-01
Patient: 45 year old male, weighing 86.0 kg (189.2 pounds)
Reactions: Pneumonia, Renal Impairment, Ileus, Respiratory Failure, Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Dosage: 3mg:05jul-07jul11, 6mg:08jul-11jul11, 9mg:12jul-19jul11.
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-07-05
End date: 2011-07-19
Cremin
Dosage: granules
Administration route: Oral
Indication: Schizophrenia
Start date: 1996-10-01
End date: 2011-07-19
Fludecasin
Indication: Schizophrenia
Start date: 2004-05-25
End date: 2011-06-20
Promethazine HCL
Administration route: Oral
Indication: Parkinsonism
Start date: 1996-10-01
End date: 2011-07-19
Pentona
Administration route: Oral
Indication: Parkinsonism
Start date: 1996-10-01
End date: 2011-07-19
Akineton
Administration route: Oral
Indication: Parkinsonism
Start date: 1996-10-01
End date: 2011-07-19
Symmetrel
Dosage: granules
Administration route: Oral
Indication: Parkinsonism
Start date: 1996-10-01
End date: 2011-07-19
Other drugs received by patient: Lasix; Trichlormethiazide; Diazepam
Possible Abilify side effects in 47 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-07
Patient: 47 year old male, weighing 79.0 kg (173.8 pounds)
Reactions: Withdrawal Syndrome, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pelex
Dosage: reg1:1g,tid;oral;13apr2012-15apr2012(3d);granules reg2:3gm,daily;oral 20apr2012-unk
Administration route: Oral
Indication: Nasopharyngitis
Start date: 2012-04-13
Calslot
Dosage: tabs
Administration route: Oral
Indication: Hypertension
Start date: 2011-12-26
Medicon
Dosage: tabs reg1:15mg,tid;oral;13apr2012-15apr2012 reg2:45mg,daily;oral;20apr2012-unk
Administration route: Oral
Indication: Nasopharyngitis
Start date: 2012-04-13
Brotizolam
Dosage: reg 2-0.5mg-15apr12-ong
Administration route: Oral
Indication: Insomnia
Start date: 2012-04-09
End date: 2012-04-15
Aripiprazole
Dosage: inj
Indication: Schizophrenia
Start date: 2011-12-12
End date: 2012-04-02
Potassium Chloride
Indication: Neuroleptic Malignant Syndrome
Start date: 2012-04-13
End date: 2012-04-15
Tathion
Dosage: injection
Indication: Neuroleptic Malignant Syndrome
Start date: 2012-04-13
End date: 2012-04-15
Diovan
Dosage: tabs
Administration route: Oral
Indication: Hypertension
Start date: 2011-05-09
Abilify
Dosage: 07aug07-26sep11;12mg,27sep11-02oct11;24mg,03oct11-12apr12;193d
Administration route: Oral
Indication: Schizophrenia
Start date: 2007-08-07
End date: 2012-04-12
NEO-Minophagen C
Indication: Neuroleptic Malignant Syndrome
Start date: 2012-04-13
End date: 2012-04-15
Dantrium
Dosage: reg 1 reg 2-16apr12-ong
Administration route: Oral
Indication: Neuroleptic Malignant Syndrome
Start date: 2012-04-13
End date: 2012-04-15
Placebo
Cefoperazone Sodium + Sulbactam Sodium
Indication: Neuroleptic Malignant Syndrome
Start date: 2012-04-13
End date: 2012-04-15
Mucosta
Dosage: tab
Administration route: Oral
Indication: Gastritis
Start date: 2006-03-22
End date: 2012-04-15
Other drugs received by patient: Livostin; Risperdal; Famotidine; Olopatadine HCL; Onon; Cleanal
Possible Abilify side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-13
Patient: female
Reactions: Cogwheel Rigidity, Confusional State, Blood Creatine Phosphokinase Increased, Urinary Tract Infection, Tachycardia, Neuroleptic Malignant Syndrome, Pyrexia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Trimeprazine Tartrate
Dosage: 10 drops in the evening
Administration route: Oral
Start date: 2012-02-02
Clozapine
Dosage: 37.5 mg, daily
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-01-31
End date: 2012-02-07
Abilify
Administration route: Oral
Start date: 2012-01-17
End date: 2012-01-30
Risperdal Consta
Start date: 2011-12-27
End date: 2012-02-03
Other drugs received by patient: Trihexyphenidyl Hydrochloride; Alprazolam; Risperdal; Imovane; Atarax
Possible Abilify side effects in 85 year old male
Reported by a physician from Poland on 2012-01-13
Patient: 85 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Death, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Abilify
Dosage: 15 mg in the morning and 15 mg in the evening last dose:15mg in mrng
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Lamotrigine
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Possible Abilify side effects in 85 year old male
Reported by a physician from Poland on 2011-12-20
Patient: 85 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Death, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abilify
Dosage: 15 mg in the morning and 15 mg in the evening last dose:15mg in mrng
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Depakene
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Lamotrigine
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Possible Abilify side effects in 17 year old male
Reported by a pharmacist from United States on 2011-12-16
Patient: 17 year old male
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abilify
Possible Abilify side effects in male
Reported by a consumer/non-health professional from United States on 2011-12-16
Patient: male
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Abilify
Dosage: duration:2 weeks approx.
Indication: Schizophrenia
Prolixin Decanoate
Dosage: duration:2 weeks approx.
Indication: Schizophrenia
Possible Abilify side effects in 19 year old male
Reported by a consumer/non-health professional from United States on 2011-12-16
Patient: 19 year old male
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zyprexa
Abilify
Effexor
Possible Abilify side effects in 17 year old male
Reported by a physician from United States on 2011-12-16
Patient: 17 year old male
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakote
Indication: Bipolar I Disorder
Haloprogin
Indication: Bipolar I Disorder
Lithium Carbonate
Indication: Bipolar I Disorder
Abilify
Administration route: Oral
Indication: Bipolar I Disorder
Possible Abilify side effects in 5 year old male
Reported by a consumer/non-health professional from United States on 2011-12-16
Patient: 5 year old male
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abilify
Other drugs received by patient: Clonidine
Possible Abilify side effects in 31 year old male
Reported by a consumer/non-health professional from United States on 2011-12-16
Patient: 31 year old male
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Abilify
Possible Abilify side effects in 5 year old male
Reported by a consumer/non-health professional from United States on 2011-12-16
Patient: 5 year old male
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Abilify
Possible Abilify side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-16
Patient: female
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Cymbalta
Abilify
Lamictal
Possible Abilify side effects in 4 year old
Reported by a consumer/non-health professional from United States on 2011-12-16
Patient: 4 year old
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Abilify
Possible Abilify side effects in 32 year old male
Reported by a consumer/non-health professional from Denmark on 2011-12-12
Patient: 32 year old male
Reactions: Electrocardiogram ST Segment Depression, Bedridden, Suicidal Ideation, Overdose, C-Reactive Protein Increased, Decubitus Ulcer, Neuroleptic Malignant Syndrome, Hallucination, Oxygen Saturation Decreased, Pneumonia, Toxicity To Various Agents, Electrocardiogram QRS Complex Shortened, Psychotic Disorder, Hallucinations, Mixed, Hypophagia, Fluid Intake Reduced, Depressed Level of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abilify
Dosage: interrupted and restarted with 15mg
Administration route: Oral
Indication: Depression
Clozapine
Dosage: interrrupted and restarted with 200 mg
Administration route: Oral
Indication: Mental Disorder
Duloxetine Hydrochloride
Dosage: gastro resistant capsule hard
Administration route: Oral
Indication: Depression
Cymbalta
Dosage: gastro resistant capsule, hard interrupted and restarted with 60mg
Administration route: Oral
Indication: Depression
Other drugs received by patient: Pantoprazole Sodium; Buprenex; Metoprolol Succinate; Simvastatin
Possible Abilify side effects in 39 year old male
Reported by a physician from United Kingdom on 2011-11-21
Patient: 39 year old male
Reactions: Blood Creatine Phosphokinase Increased, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Valproate Sodium
Indication: Schizophrenia, Paranoid Type
Start date: 2008-02-05
End date: 2008-03-02
Clozapine
Indication: Schizophrenia, Paranoid Type
End date: 2007-12-17
Lithium Carbonate
Indication: Schizophrenia, Paranoid Type
Start date: 2008-03-06
End date: 2008-06-18
Quetiapine Fumarate
Dosage: at bedtime
Indication: Schizophrenia, Paranoid Type
Start date: 2008-01-01
End date: 2008-01-08
Valproate Sodium
Start date: 2008-03-06
Depixol
Indication: Schizophrenia, Paranoid Type
End date: 2007-12-17
Abilify
Indication: Schizophrenia, Paranoid Type
Start date: 2008-02-18
End date: 2008-02-23
Valproate Sodium
Start date: 2008-03-03
End date: 2008-03-05
Chlorpromazine
Indication: Schizophrenia, Paranoid Type
End date: 2007-12-17
Clozapine
Start date: 2008-01-29
End date: 2008-02-05
Procyclidine Hydrochloride 2MG TAB
Indication: Schizophrenia, Paranoid Type
End date: 2007-12-17
Clozapine
Start date: 2008-03-26
Other drugs received by patient: Lorazepam; Antibiotics; Hyoscine Hydrobromide
Possible Abilify side effects in 8 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-14
Patient: 8 year old male, weighing 24.5 kg (53.9 pounds)
Reactions: Neuroleptic Malignant Syndrome, Salivary Hypersecretion, Swollen Tongue, Tremor
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Abilify
Possible Abilify side effects in 68 year old
Reported by a consumer/non-health professional from Germany on 2011-11-11
Patient: 68 year old , weighing 120.0 kg (264.0 pounds)
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Possible Abilify side effects in 39 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-10
Patient: 39 year old male
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Hyoscine HBR HYT
Indication: Salivary Hypersecretion
Clozapine
Indication: Schizophrenia, Paranoid Type
Start date: 2008-01-29
End date: 2008-02-05
Abilify
Dosage: 10mg in the morning
Indication: Schizophrenia, Paranoid Type
Start date: 2008-02-18
End date: 2008-02-23
Quetiapine
Dosage: 50mg at night
Indication: Schizophrenia, Paranoid Type
Start date: 2008-01-01
End date: 2008-01-08
Valproate Sodium
Clozapine
Start date: 2008-03-26
Other drugs received by patient: Lorazepam; Chlorpromazine; Procyclidine Hydrochloride 2MG TAB; Diazepam; Depakote; Clozapine; Depixol; Lithium
Page 1 Next >>
|
